`
`RePub, Erasmus University Repository: Aspects of medical therapy of neuroendocrine disorders
`
`WEALTH HEALTH GOVERNANCE CULTURE SUBMISSIONS
`
`A.J. van der Lelij (Aart Jan)
`
`1992-05-27
`
`Aspects of medical therapy of
`neuroendocrine disorders
`
`Aspecten van de medicamenteuze behandeling van neuroendocriene ziekten
`
`Treatment of pituitary diseases bas changed considerably over the last 35 years. Apart from the introduction of
`transspbenoidal surgery the development of dopaminergic drugs, as well as of the somatostatin analog
`octreotide have been major steps forward towards the control of the growth and hormonal byperproduction by
`pituitary adenomas. The improved understanding of the interaction between hormones and their receptors, the
`knowledge about hypothalamic releasing factors and hormones, as well as the development of RIA- and ELISA
`techniques for the measurement of circulating hormone and growth factor levels have also contributed to this
`progress in treatment. This thesis is dealing with some aspects of the medical treatment of neuroendocrine
`disorders
`
`Additional Metadata
`
`Keywords
`
`ELISA technique, RIA technique, pituitary diseases, treatment
`
`Promotor
`
`Publisher
`
`S.W.J. Lamberts (Steven)
`
`Erasmus University Rotterdam
`
`Persistent URL
`
`hdl.handle.net/1765/39782
`
`Citation
`
`APA Style
`APA Style
`
`van der Lelij, A.J. (1992, May 27). Aspects of medical therapy of neuroendocrine disorders. Erasmus
`University Rotterdam. Retrieved from http://hdl.handle.net/1765/39782
`
` Free Full Text ( Final Version , 3mb )
`
`https://repub.eur.nl/pub/39782
`
`1/3
`
`1
`
`TEVA1077
`Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc.
`PGR2019-00048
`
`
`
`5/21/2020
`
`RePub, Erasmus University Repository: Aspects of medical therapy of neuroendocrine disorders
`
`Additional Files
`
` 0841_LELIJ, Aart Johannes van der.jpg
`
` stellingen Lelij.pdf
`
`Cover Image , 87kb
`
`, 38kb
`
` Feedback
` Feedback
`
`Contact
`
` RePub Repository Team
`https://repub.eur.nl/pub/39782
`
`2/3
`
`2
`
`
`
`5/21/2020
`About
`
`RePub, Erasmus University Repository: Aspects of medical therapy of neuroendocrine disorders
`
`Submitting a Publication
`Research Matters
`Open Access
`Privacy Statement
`
`https://repub.eur.nl/pub/39782
`
`3/3
`
`3
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
